发明名称 SOLID PHARMACEUTICAL COMPOSITION WITH ENHANCERS AND PREPARATION METHODS THEREFOR
摘要 PROBLEM TO BE SOLVED: To provide an oral dosage form having reasonable characteristics that provide for sufficient absorption of the active ingredient.SOLUTION: An oral dosage form, which is effective in providing therapeutically effective blood levels of a therapeutically active ingredient to a subject when administered to a gastrointestinal tract, comprises: (i) a therapeutically effective amount of a therapeutically active ingredient; (ii) at least one water soluble enhancer, e.g. a medium chain fatty acid or a salt, ester, or ether of a medium chain fatty acid, which has a carbon chain length of from about 8 to 14 carbon atoms; and (iii) a saccharide, e.g. sugar alcohols, monosaccharides, di-saccharides and oligosaccharides, wherein the weight ratio of the enhancer to saccharide is 4:1 to 6:1. The oral dosage form provides rapid release of the active ingredient and the enhancer after the pharmaceutical composition enters the intestine of a subject; and, in the form of a dosage form without coating, provides an in vitro dissolution of at least 80% of the therapeutically active ingredient and the enhancer in 20 minutes, preferably in 18 minutes.SELECTED DRAWING: None
申请公布号 JP2016155811(A) 申请公布日期 2016.09.01
申请号 JP20160021689 申请日期 2016.02.08
申请人 MERRION RESEARCH III LTD 发明人 DAVID C COUGHLAN;LEONARD THOMAS W;BOZENA ADAMCZYK;KIERAN MADIGAN;EDEL O'TOOLE;ALAN CULLEN;JASON O'HARA
分类号 A61K9/20;A61K9/16;A61K9/48;A61K31/663;A61K31/675;A61K31/727;A61K38/00;A61K38/28;A61K47/08;A61K47/10;A61K47/12;A61K47/14;A61K47/30;A61P19/08 主分类号 A61K9/20
代理机构 代理人
主权项
地址